By comparing levels of best-known Notch target genes and incidences of gain-of-function events in Id1 and N1C-expressing tumor samples, we conclude that a large fraction of Id1-expressing tumors exhibit evidence of significant Notch activation. This evidence concerns the gene ID1 and neoplasm.